International
Dragon Pharma PT-141 10 mg Bremelanotide Research Peptide Vial
Injection · 10 mg · vial
PT-141 is bremelanotide, a melanocortin peptide in a 10 mg research vial. It acts centrally on desire through MC4 receptors, not on blood flow like a PDE5 inhibitor. The approved prescription form uses a fixed 1.75 mg dose, but the powder has no validated dosing.
GMP-manufactured and HPLC-verified, with a COA per batch. Dragon Pharma PT-141 10 mg for sale with international and U.S. domestic shipping.
Product overview
Dragon Pharma PT-141 10 mg Bremelanotide Research Vial
Bremelanotide, known as PT-141, is a melanocortin receptor agonist that works mainly at the MC4 receptor in the brain. That is the important distinction from the PDE5 inhibitors: Viagra and Cialis act on blood flow, while PT-141 acts on the central pathway behind desire and arousal. The catalogue keeps it alongside the other small peptides such as Melanotan II, which shares the melanocortin receptor family but has a different profile.
- Bremelanotide 10 mg per lyophilized research vial
- Melanocortin receptor agonist, mainly MC4, central action
- Half-life about 2.7 hours in the approved product (range 1.9 to 4.0)
- GMP-manufactured and HPLC-verified, COA on file per batch
How Bremelanotide Works
Melanocortin receptors sit in the central nervous system and influence appetite, pigmentation and sexual desire. Bremelanotide activates MC4 in particular, which is why it changes the motivational side of sexual response rather than the vascular side. The approved prescription product is a subcutaneous injection of 1.75 mg given as needed, and references give it a half-life of about 2.7 hours, with a reported range of 1.9 to 4.0 hours.
Research Handling
This 10 mg vial is a lyophilized research powder, not the formulated prescription product, and no validated dose exists for it. It is dissolved with bacteriostatic water added slowly down the wall of the vial, and the solution is kept refrigerated. Nausea, flushing and headache are the most commonly reported effects of the drug class, and the prescription version carries a warning about blood pressure changes and darkening of the skin with repeated use.
Quality & Authenticity
Each batch is produced under GMP conditions and checked by third-party HPLC, with a Certificate of Analysis held for the batch. Keep lyophilized vials cold and dry, refrigerate the reconstituted solution, and do not freeze it.
For laboratory research only. Consult a healthcare professional before use.
Specifications
| Trade Name | PT-141 (Vyleesi reference) |
| Generic Name | Bremelanotide |
| Manufacturer | Dragon Pharma |
| Dosage | 10 mg per vial |
| Package | Lyophilized single vial, diluent not included |
| Drug Class | Melanocortin receptor agonist (mainly MC4), research peptide |
| Administration | Reconstituted with bacteriostatic water, research handling only |
| Reference Half-Life | About 2.7 hours, range 1.9 to 4.0 hours |
| Prescription Reference | 1.75 mg subcutaneous in the approved product |
| Shipping | International and U.S. domestic options, both active |
Stacks
Consult a healthcare professional before any cycle. Doses are common community protocols.
FAQ
Before you ask
Questions, answered
It is bremelanotide, a melanocortin peptide sold as a 10 mg lyophilized vial. Published use of the molecule is for low sexual desire, because it acts centrally at the MC4 receptor rather than on blood flow. This vial is supplied as a research powder, so it is handled as a research material and not as a formulated medicine with a fixed dose.
The targets are completely different. Viagra and Cialis block PDE5 and change blood flow, so they need arousal to work at all. Bremelanotide activates melanocortin receptors in the brain, which influences the motivational side of sexual response. That is why a person who does not respond to a PDE5 inhibitor may still respond to PT-141, and vice versa.
The prescription form is a fixed 1.75 mg subcutaneous injection used as needed, and references give it a half-life of about 2.7 hours, with a reported range of 1.9 to 4.0 hours. That figure describes the formulated medicine, not this powder. No validated dose exists for the research vial, and nothing on this page should be read as a human dosing instruction for it.
The vial contains lyophilized powder that is dissolved with bacteriostatic water before use. Add the water slowly down the inside wall of the vial and swirl gently instead of shaking, because small peptides are easily damaged. Keep the solution refrigerated afterwards and use it within its stability window, and never freeze it.
Nausea, flushing and headache are the most commonly reported effects, and they are usually strongest with the first doses. The approved product carries warnings about temporary rises in blood pressure and about darkening of the skin with repeated use. Because this vial is unformulated powder, no human safety profile can be assumed for it in any dose.
Yes. The 10 mg vial is listed in stock at 45.00 USD for international shipping and 95.00 USD for U.S. domestic delivery, and both shipping blocks are active on the page. The price shown is the price charged for the selected option. Items sold here are intended strictly for laboratory research.
Be the first to share your experience with Dragon Pharma PT-141 10 mg Bremelanotide Research Peptide Vial
Log in to write a reviewComplete the cycle
Stack it with
International
International
Available Domestic
Available Domestic
Dragon Pharma Kisspeptin 10 mg (Metastin) Research Peptide Vial
Out of stock